002082.SZ
Wanbangde Pharmaceutical Holding Group Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 9.44
−3.77%Margins
Gross margin
42.2%
EBITDA margin
-3.5%
EBIT margin
-4.1%
Net margin
-6.8%
FCF margin
30.5%
-3.0%
Return on equity
-1.7%
Return on assets
-1.4%
Return on invested capital
0.26x
Asset turnover
CNY 729.1M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026